chrX-44261277-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_025184.4(EFHC2):c.404G>A(p.Arg135Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00116 in 1,189,572 control chromosomes in the GnomAD database, including 4 homozygotes. There are 618 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00079 ( 0 hom., 33 hem., cov: 22)
Exomes 𝑓: 0.0012 ( 4 hom. 585 hem. )
Consequence
EFHC2
NM_025184.4 missense
NM_025184.4 missense
Scores
2
5
7
Clinical Significance
Conservation
PhyloP100: 2.63
Genes affected
EFHC2 (HGNC:26233): (EF-hand domain containing 2) This gene encodes a protein which contains three DM10 domains and three calcium-binding EF-hand motifs. A related protein is encoded by a gene on chromosome 6. It has been suggested that both proteins are involved in the development of epilepsy (PMID: 15258581, 16112844) and that this gene may be associated with fear recognition in individuals with Turner syndrome. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009518921).
BS2
High Hemizygotes in GnomAd4 at 33 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFHC2 | NM_025184.4 | c.404G>A | p.Arg135Gln | missense_variant | 4/15 | ENST00000420999.2 | NP_079460.2 | |
EFHC2 | XM_047442535.1 | c.404G>A | p.Arg135Gln | missense_variant | 4/14 | XP_047298491.1 | ||
EFHC2 | XM_047442536.1 | c.404G>A | p.Arg135Gln | missense_variant | 4/15 | XP_047298492.1 | ||
EFHC2 | XM_006724562.3 | c.-185G>A | 5_prime_UTR_variant | 3/14 | XP_006724625.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFHC2 | ENST00000420999.2 | c.404G>A | p.Arg135Gln | missense_variant | 4/15 | 1 | NM_025184.4 | ENSP00000404232.2 |
Frequencies
GnomAD3 genomes AF: 0.000821 AC: 92AN: 111998Hom.: 0 Cov.: 22 AF XY: 0.00102 AC XY: 35AN XY: 34164
GnomAD3 genomes
AF:
AC:
92
AN:
111998
Hom.:
Cov.:
22
AF XY:
AC XY:
35
AN XY:
34164
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00214 AC: 362AN: 168995Hom.: 2 AF XY: 0.00270 AC XY: 152AN XY: 56365
GnomAD3 exomes
AF:
AC:
362
AN:
168995
Hom.:
AF XY:
AC XY:
152
AN XY:
56365
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00120 AC: 1293AN: 1077522Hom.: 4 Cov.: 30 AF XY: 0.00169 AC XY: 585AN XY: 345996
GnomAD4 exome
AF:
AC:
1293
AN:
1077522
Hom.:
Cov.:
30
AF XY:
AC XY:
585
AN XY:
345996
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000794 AC: 89AN: 112050Hom.: 0 Cov.: 22 AF XY: 0.000964 AC XY: 33AN XY: 34226
GnomAD4 genome
AF:
AC:
89
AN:
112050
Hom.:
Cov.:
22
AF XY:
AC XY:
33
AN XY:
34226
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
341
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 20, 2013 | - - |
X-linked intellectual disability Benign:1
Benign, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | - | The p.Arg135Gln variant in EFHC2 has been identified in at least 2 unrelated individuals with intellectual disability, segregated with disease in 2 families of unknown size (PMID: 17221867), and has been identified in >1% of South Asian chromosomes, 100 hemizygotes, and 1 homozygote by ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for X-linked recessive mental retardation. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Benign
T
REVEL
Uncertain
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at